Genesys Capital-backed Invitae goes public with $102 mln raise
Genetic information company Invitae Corp has priced its initial public offering of common shares at US$16 per share, which will raise gross proceeds totaling US$101.6 million. Invitae's shares are expected to begin trading this week on the New York Stock Exchange under the symbol “NVTA”. Based in San Francisco, the company secured US$120 million in a Series F round last October. One of the investors in that round, and in earlier Invitae financings, was Genesys Capital, a Canadian venture capital firm focused on investing in healthcare and biotechnology sectors.
13 February 2015•2 mins read
